PCN74 A SERVICE EVALUATION TO COMPARE SECONDARY CARE RESOURCE USE BETWEEN XELOX AND FOLFOX-6 REGIMENS IN THE TREATMENT OF METASTATIC COLORECTAL CANCER (MCRC) FROM A UK NATIONAL HEALTH SERVICE (NHS) PERSPECTIVE
Nov 1, 2008, 00:00 AM
10.1016/S1098-3015(10)66610-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)66610-7/fulltext
Section Title :
Section Order :
446
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66610-7&doi=10.1016/S1098-3015(10)66610-7